David Ladkani

Person

Kiriat Yovel, IL

People

Patents Grantslast 30 patents

Information Patent Grant
Genetic markers predictive of response to glatiramer acetate
- Patent number 9,702,007
- Issue date Jul 11, 2017
- TEVA PHARMACEUTICALS INDUSTRIES, LTD.
- Amir Tchelet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of cholecalciferol derivatives for the treatment of ren...
- Patent number 4,997,824
- Issue date Mar 5, 1991
- Teva Pharmaceutical Industries Ltd.
- Mordecai Popovtzer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Preparation of 1'-ethoxycarbonyl-oxyethyl esters of penicillins
- Patent number 4,889,929
- Issue date Dec 26, 1989
- Astra Lakemedel Aktiebolag
- Jacob Vaya
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory c...
- Patent number 4,851,426
- Issue date Jul 25, 1989
- Teva Pharmaceutical Industries, Ltd.
- David Ladkani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
1'-ethoxycarbonyloxyethyl ester of valproic acid, its preparation a...
- Patent number 4,595,695
- Issue date Jun 17, 1986
- Teva Pharmaceutical Industries Ltd.
- David Ladkani
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
GENETIC MARKERS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATE
- Publication number 20180002753
- Publication date Jan 4, 2018
- Teva Pharmaceutical Industries, Ltd.
- Amir TCHELET
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Treatment Of Neurodegenerative Diseases With Combination Of Laquini...
- Publication number 20170354651
- Publication date Dec 14, 2017
- Teva Pharmaceutical Industries Ltd.
- Michael Hayden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment Of Neurodegenerative Diseases With Combination Of Laquini...
- Publication number 20170224674
- Publication date Aug 10, 2017
- Teva Pharmaceutical Industries Ltd.
- Michael Hayden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BIOLOGICAL CHARACTERIZATION OF A GLATIRAMER ACETATE RELATED DRUG PR...
- Publication number 20170003277
- Publication date Jan 5, 2017
- Michael Hayden
- G01 - MEASURING TESTING
Information Patent Application
METHOD OF INDUCING ANTI-GLATIRAMER ACETATE ANTIBODY RESPONSE
- Publication number 20160213633
- Publication date Jul 28, 2016
- Teva Pharmaceutical Industries, Ltd.
- David Ladkani
- G01 - MEASURING TESTING
Information Patent Application
Treatment Of Neurodegenerative Diseases With Combination Of Laquini...
- Publication number 20160074380
- Publication date Mar 17, 2016
- Teva Pharmaceutical Industries Ltd.
- Michael Hayden
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GENETIC MARKERS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATE
- Publication number 20150110733
- Publication date Apr 23, 2015
- Teva Pharmaceutical Industries, Ltd.
- Amir TCHELET
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Method of Delaying The Onset of Clinically Definite Multiple Sclerosis
- Publication number 20100305023
- Publication date Dec 2, 2010
- Teva Pharmaceutical Industries, Ltd.
- Yafit Stark
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

David Ladkani

Person

Patents Grantslast 30 patents

Genetic markers predictive of response to glatiramer acetate

Combination of cholecalciferol derivatives for the treatment of ren...

Preparation of 1'-ethoxycarbonyl-oxyethyl esters of penicillins

Ethoxycarbonyloxy ethyl esters of non-steroidal anti-inflammatory c...

1'-ethoxycarbonyloxyethyl ester of valproic acid, its preparation a...

Patents Applicationslast 30 patents

GENETIC MARKERS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATE

Treatment Of Neurodegenerative Diseases With Combination Of Laquini...

Treatment Of Neurodegenerative Diseases With Combination Of Laquini...

BIOLOGICAL CHARACTERIZATION OF A GLATIRAMER ACETATE RELATED DRUG PR...

METHOD OF INDUCING ANTI-GLATIRAMER ACETATE ANTIBODY RESPONSE

Treatment Of Neurodegenerative Diseases With Combination Of Laquini...

GENETIC MARKERS PREDICTIVE OF RESPONSE TO GLATIRAMER ACETATE

Method of Delaying The Onset of Clinically Definite Multiple Sclerosis